Re: Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease.
M D
MD
Kittleson
J D
JD
Bonagura
D000818:Animals; D004232:Diuretics / Q000627:therapeutic use*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D017277:Drug Approval; D016127:Heart Valve Prolapse / Q000150:complications / Q000662:veterinary*; D008944:Mitral Valve Insufficiency / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary*; D013148:Spironolactone / Q000627:therapeutic use*
D004232:Diuretics; D013148:Spironolactone